Innovative Closure Technology Vivasure Medical specializes in fully absorbable, patch-based vessel closure devices, representing advanced minimally invasive solutions with unique bioresorbable features ideal for hospitals seeking next-generation endovascular tools.

Regulatory Achievements Recent CE mark approvals for the PerQseal Elite system demonstrate the company's ability to meet stringent European regulatory standards, paving the way for sales expansion within the EU and facilitating future U.S. market entry.

Strong Investment Backing Significant funding rounds, including a €30M strategic investment from Haemonetics and over $32M in total funding, highlight investor confidence and potential for scaling sales efforts across cardiovascular and vascular intervention markets.

Market Expansion Potential Ongoing development of additional devices like PerQseal Blue indicates a strategic focus on diverse vascular closure solutions, presenting cross-selling opportunities within hospitals performing multiple transcatheter procedures.

Strategic Industry Partnerships Support from Enterprise Ireland and European Investment Bank underscores a strong network of public and private partnerships, offering avenues for collaborative sales efforts and access to broader healthcare markets domestically and internationally.